Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vsv-Gp128
Colorectal Cancer
Amal Therapeutics
P1
C
(36)
Vvd-133214
Colorectal Cancer
Vividion Therapeutics, Inc.
P1
C
(36)
Wm-A1-3389
Colorectal Cancer
Wellmarker Bio
P1
C
(36)
zm008
Colorectal Cancer
Zumutor Biologics Inc.
P1
C
(36)
68ga-nodaga-sna009
Colorectal Cancer
SmartNuclide Biopharma
Early P1
C
(36)
(3RS)-1-(6-(.ALPHA.-METHYLPOLY(OXYETHYLENE)AMINO)-6-OXOHEXYL)-2,5-DIOXOPYRROLIDIN-3-YL)-L-CYSTEINAMIDE, (20000 MW)
Colorectal Cancer
Lumicell, Inc.
P1/2
C
(36)
gi-6207
Colorectal Cancer
National Cancer Institute (NCI)
P1/2
C
(34)
HUMAN INTERLEUKIN 2 (IL2, T-CELL GROWTH FACTOR, TCGF) (2-133) VARIANT (A1 DELETED, PRO65>LYS, CYS125>SER), NON-GLYCOSYLATED, PRODUCED IN ESCHERICHIA COLI, CONJUGATED AT N6 OF K65 WITH A PEG DERIVATIVE (30KDA)
Colorectal Cancer
Sanofi
P2
C
(33)
64Cu-EB-ss-CPT
Colorectal Cancer
Peking Union Medical College Hospital
Early P1
C
(33)
68ga-eb-ss-cpt
Colorectal Cancer
Peking Union Medical College Hospital
Early P1
C
(33)
Autologous, Engineered T Cells Targeting Tp53 R248Q
Colorectal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(33)
Montelukast
Colorectal Cancer
University of South Florida
Early P1
C
(33)
nk510
Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Early P1
C
(33)
R130
Colorectal Cancer
Shanghai Yunying Medical Technology
Early P1
C
(33)
Semaglutide
Colorectal Cancer
University of Arizona
Early P1
C
(33)
VGT-309
Colorectal Cancer
Stephan Rogalla
Early P1
C
(33)
Nanrilkefusp Alfa
Colorectal Cancer
SOTIO Biotech AG
P2
D
(29)
68ga-nota-gpa33 nanobody
Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
N/A
D
(26)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER
Colorectal Cancer
Rush University Medical Center
N/A
D
(26)
BLOOD, WHOLE
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
N/A
D
(26)
FLURBIPROFEN
Colorectal Cancer
Fudan University
N/A
D
(26)
HUMAN PERIPHERAL BLOOD LEUKOCYTES
Colorectal Cancer
A2 Biotherapeutics Inc.
D
(26)
Ketorolac Tromethamine
Colorectal Cancer
Cairo University
N/A
D
(26)
Luminomark Inj. 0.
Colorectal Cancer
Seoul St. Mary's Hospital
N/A
D
(26)
MEGESTROL ACETATE IMPURITY B
Colorectal Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
D
(26)
Showing 376 to 400 of 414 assets
Previous
Page 16 of 17
Next
